Karen Mangasarian counsels biotechnology, pharmaceutical, and other life sciences clients on all aspects of intellectual property. She has extensive experience in the management of worldwide patent portfolios, patent life cycle management, and the development of competitive patent strategies. She assists clients with competitive patent landscapes, patent invalidity, patentability, non-infringement, and freedom-to-operate analyses.
Karen performs IP due diligence investigations and advises on IP issues in the context of transactions, including license agreements, joint ventures, collaboration agreements, and mergers and acquisitions.
Karen has successfully worked with clients across a wide range of technology areas in life sciences including small molecule pharmaceuticals, pharmaceutical formulations, antibodies, protein therapeutics, gene therapy, CRISPR and diagnostic and therapeutic methods in molecular and cellular biology, immunology, microbiology, biochemistry, genomics, and computational biology.
Karen also has extensive experience in contentious patent matters, including interferences, reexaminations, oppositions, and litigation.
Education/Alumni:
- J.D., 2000, New York Law School, magna cum laude
- Post-doctoral Fellow, 1992-1996, Microbiology, New York University Medical Center
- Ph.D., Pharmacology, 1992, University of Wisconsin-Madison
- B.S., Biochemistry,1984, University of Wisconsin-Madison
Network Memberships:
- New York Intellectual Property Association
- Intellectual Property Owners Association (IPO)
- Pharmaceutical & Biotechnology Issues Committee
